Cite
Predictors of the utility of clinical exome sequencing as a first-tier genetic test in patients with Mendelian phenotypes: results from a referral center study on 603 consecutive cases.
MLA
Alix, Tom, et al. “Predictors of the Utility of Clinical Exome Sequencing as a First-Tier Genetic Test in Patients with Mendelian Phenotypes: Results from a Referral Center Study on 603 Consecutive Cases.” Human Genomics, vol. 17, no. 1, Feb. 2023, p. 5. EBSCOhost, https://doi.org/10.1186/s40246-023-00455-x.
APA
Alix, T., Chéry, C., Josse, T., Bronowicki, J.-P., Feillet, F., Guéant-Rodriguez, R.-M., Namour, F., Guéant, J.-L., & Oussalah, A. (2023). Predictors of the utility of clinical exome sequencing as a first-tier genetic test in patients with Mendelian phenotypes: results from a referral center study on 603 consecutive cases. Human Genomics, 17(1), 5. https://doi.org/10.1186/s40246-023-00455-x
Chicago
Alix, Tom, Céline Chéry, Thomas Josse, Jean-Pierre Bronowicki, François Feillet, Rosa-Maria Guéant-Rodriguez, Farès Namour, Jean-Louis Guéant, and Abderrahim Oussalah. 2023. “Predictors of the Utility of Clinical Exome Sequencing as a First-Tier Genetic Test in Patients with Mendelian Phenotypes: Results from a Referral Center Study on 603 Consecutive Cases.” Human Genomics 17 (1): 5. doi:10.1186/s40246-023-00455-x.